The Biotech Capital Compass
Biotechnology & ‘Fog of Valuation’ savant
| Platform |  | Pricing | Freemium | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 210 | Founded | 2 years ago | Last Issue | 3 days ago |
| Active | |||||
Read this Newsletter
hartajsingh1.substack.comLatest Issues
Video Companion: Thermo Fisher and the Industrialization of Modern Biology
Thermo Fisher Scientific is often described as a life sciences tools company. Increasingly, however, it may be more accurately understood as an infrastructure company helping industrialize modern biology.
In this Video Companion, we explor...
The Long Climb: Building the Bridge Before Growth Returns
Part I examines how Sarepta Therapeutics is navigating an unprecedented setback—and how investors should think about biotechnology recoveries when expectations collapse.
The most uncomfortable place to invest in biotechnology is often imme...
The Biotech Tape Check: Is Biotechnology Beginning to Feel Normal Again?
Over the past two years, biotechnology investors have spent an enormous amount of time asking whether something was fundamentally broken—capital markets, financing conditions, investor sentiment, or biotechnology itself.
Today, we find our...
The Skeptical Lens: Competition Creates Markets. Commercialization Builds Companies. Strategic Intent Shapes Their Future.
Part 2 of Competition Becomes Diligence examines how Syndax, Kura and Biomea are responding to the same scientific opportunity—and what investors should look for once commercialization begins.
Competition often validates science. What happ...
The Biotech Tape Check: Following the Money Through Biotech’s Capital Flywheel
Biotech M&A has returned, but the bigger story may be where the proceeds ultimately flow. We examine whether successful exits are beginning to finance the next generation of biotechnology innovation.
In this Sunday edition of the Biotech T...
Audience Metrics
Subscribers, engagement, traffic and sponsorship for The Biotech Capital Compass.
| Subscribers | Engagement | 71 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Biotech Capital Compass breaks down complex biotech stories into valuation, risk, and narrative frameworks investors can use. Written by Hartaj Singh, a biotech analyst focused on translating innovation into investment reality.
Frequently Asked Questions
How can I access the email archive for The Biotech Capital Compass?
You can find recent issues that have been published by The Biotech Capital Compass on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does The Biotech Capital Compass have?
To see how many people subscribe to The Biotech Capital Compass, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in The Biotech Capital Compass?
Newsletter advertising can be extremely effective when it's done right. Before you pitch The Biotech Capital Compass as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like The Biotech Capital Compass?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The Biotech Capital Compass using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to The Biotech Capital Compass?
Scroll up to where it says Related Newsletters to see other publications like The Biotech Capital Compass. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact The Biotech Capital Compass?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.